argenx
The Clinical Operations Development Lead (CODL) at argenx is responsible for overseeing clinical activities within specific therapeutic indications for assets. This role involves co-leading the Clinical Development Team and ensuring the execution of the Clinical Development Plan while collaborating with various functional areas. The CODL contributes to the strategic direction of clinical trials and resources, facilitating a comprehensive approach to advancing autoimmune therapies.
Headquarters
Boston, Massachusetts, United States
Company Size
1001-5000 employees
Founded
2008
Reaching Patients Through Immunology Innovation
Headquarters
San Francisco, CA
Company Size
201-500 employees
Founded
2018
Industry
Technology
Glassdoor Rating
4.2 / 5
Sarah Johnson
Chief Executive Officer
Michael Chen
Chief Technology Officer
Emily Williams
VP of Engineering
David Rodriguez
VP of Product
Jessica Thompson
Chief Financial Officer
Andrew Park
VP of Sales
View leadership team, funding history,
and employee contacts for argenx.
OMG—argenx scores again with Vyvgart in ocular myasthenia gravis
2 weeks ago
Clinical Development Lead, Neuroscience
Bristol Myers Squibb
Vice President, Clinical Development
Precision for Medicine
Clinical Trial Associate
ICON
Clinical Research Associate (in-house)
Artiva Biotherapeutics
Senior Medical Director, Clinical Development Endocrinology
Ascendis Pharma
Senior Clinical Trial Associate
Vor Bio